GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » PensionAndRetirementBenefit

WuXi XDC Cayman (HKSE:02268) PensionAndRetirementBenefit : HK$0 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman PensionAndRetirementBenefit?

WuXi XDC Cayman's PensionAndRetirementBenefit for the quarter that ended in Jun. 2024 was HK$0 Mil.


WuXi XDC Cayman PensionAndRetirementBenefit Historical Data

The historical data trend for WuXi XDC Cayman's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman PensionAndRetirementBenefit Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
- - - -

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PensionAndRetirementBenefit Get a 7-Day Free Trial - - - - -

WuXi XDC Cayman PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


WuXi XDC Cayman Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Executives
Wuxi Biologics (cayman) Inc. 2101 Beneficial owner
Wuxi Apptec Co., Ltd.
Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si

WuXi XDC Cayman Headlines

No Headlines